Fidelity International
AGN.PRA

Fidelity International’s Allergan plc AGN.PRA Stock Holding History

Fidelity International’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,610
Closed -$1.52M – 549
2017
Q4 		$1.52M Sell
2,610
-1,470
-36% -$949K ﹤0.01% 473
2017
Q3 		$2.99M Hold
4,080
– – 0.01% 428
2017
Q2 		$3.53M Hold
4,080
– – 0.01% 415
2017
Q1 		$3.46M Sell
4,080
-7,000
-63% -$5.8M 0.01% 434
2016
Q4 		$8.45M Hold
11,080
– – 0.02% 351
2016
Q3 		$9.1M Sell
11,080
-180
-2% -$156K 0.03% 339
2016
Q2 		$9.39M Hold
11,260
– – 0.03% 335
2016
Q1 		$10.3M Hold
11,260
– – 0.03% 328
2015
Q4 		$11.6M Buy
11,260
+350
+3% +$352K 0.04% 324
2015
Q3 		$10.3M Buy
10,910
+7,870
+259% +$8.21M 0.04% 335
2015
Q2 		$3.17M Buy
+3,040
New +$3.18M 0.01% 452

Other funds holding AGN.PRA

PWS
Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

Fidelity International's AGN.PRA Position: Q1 2018 in Review

Fidelity International sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 2,610 shares — an estimated $1.52M sold.

Fidelity International first reported a position in AGN.PRA in Q2 2015 and held it in 11 quarters. The position peaked at $11.6M in Q4 2015. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

  • Fidelity International reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Fidelity International sold 2,610 Allergan plc shares in Q1 2018, an estimated $1.52M.
  • Fidelity International first reported a position in Allergan plc in Q2 2015 and held it in 11 quarters.
  • Fidelity International's Allergan plc position peaked at $11.6M in Q4 2015.
  • 1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Fidelity International's 13F filing for Q1 2018, filed 14 May 2018.